It was a pleasure to speak to Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) about his presentation at AGS 2021, investigating cell intrinsic and microenvironmental modulators of retinal ganglion cell survival and retinal integration following transplantation.
- What were the aims and design of your study investigating cell intrinsic and microenvironmental modulators of retinal ganglion cell survival and retinal integration following transplantation? (00:14)
- What were the findings of your study and what are their implications for future research? (04:05)
Speaker Disclosure: Thomas V Johnson has no financial or non-financial relationships or activities to declare in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AGS 2021.
Share this Video
Related Videos In Glaucoma
Sarah Van Tassel, Kiaweh Eye 2021: Challenges and Benefits of Drug Delivery Devices in Glaucoma
We were delighted to catch up with Sarah Van Tassel (Weill Cornell Medicine, NY, USA), who shared her observations on the challenges and benefits of drug delivery devices in glaucoma, the intraocular devices currently on the market and what to watch out for in future. What are the challenges and benefits of drug delivery […]
Sarah Van Tassel, Kiaweh Eye 2021: New Drugs and Drug Delivery Options for Glaucoma Management
It was a pleasure to speak with Sarah Van Tassel (Weill Cornell Medicine, NY, USA) on her thoughts about the new therapeutic options for glaucoma management and the promising new combinations on the horizon. How has the pharmaceutical landscape for glaucoma developed in the last year? (00:12) Where do rho-kinase inhibitors sit in the treatment […]
Thomas V Johnson, AGS 2021: Current Status and Future Challenges of Stem Cell-based Retinal Ganglion Cell Transplantation in Glaucoma Therapy
We were delighted to speak with Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) and find out his thoughts on the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy, and the challenges and opportunities of the online format of this year’s virtual meeting. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!